Actuate Therapeutics, Inc. Common stock

NasdaqGM: ACTU · Healthcare

Positivity Index

#5,695 / 6,774

Global

#3,149 / 4,000

United States

Positivity Score

16,223

Rank→

PosiRed: 1 active red flag (highest severity 6/10) View flag history →

PosiRed · red flag

Stock exchange listing-rule deficiency notice (8-K Item 3.01)

The company reported in a Form 8-K (Item 3.01) filed on 17 Jul 2026 that its stock exchange notified it of not meeting a continued-listing rule. Continued non-compliance can lead to delisting.

More details →

Actuate Therapeutics, Inc. Common stock — Overview & Financial Snapshot

Actuate Therapeutics, Inc. Common stock (NasdaqGM: ACTU) is a Healthcare company, ranked #5,695 of 6,774 companies globally and #3,149 of 4,000 in United States on PositoAI, with a Positivity Score of 16,223. Its market capitalisation is ₹117.01 Cr ($12.40M), P/E ratio is -0.6 and P/B ratio is 12.53. It currently has 1 active red flag (PosiRed) and no yellow flags (PosiYellow) on record.

For financial statements, ratio trends and score history, Go Deep →

What does Actuate Therapeutics, Inc. Common stock do?

Actuate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancers in the United States. The company's lead product candidate is elraglusib injection, a glycogen synthase kinase-3 inhibitor that is in Phase 2 trial to treat metastatic pancreatic ductal…

What is Actuate Therapeutics, Inc. Common stock's P/E and P/B ratio?

Actuate Therapeutics, Inc. Common stock has a P/E ratio of -0.6 and a P/B ratio of 12.53.

What is Actuate Therapeutics, Inc. Common stock's debt-to-equity ratio?

Actuate Therapeutics, Inc. Common stock has a debt-to-equity ratio of 0.00.

How much does Actuate Therapeutics, Inc. Common stock owe compared with what it owns?

Actuate Therapeutics, Inc. Common stock owes $0.81 for every $1 it owns (balance sheet Jun 2026), which is high.

What is Actuate Therapeutics, Inc. Common stock's Positivity rank?

Actuate Therapeutics, Inc. Common stock is ranked #5,695 of 6,774 companies globally and #3,149 of 4,000 in United States on PositoAI, with a Positivity Score of 16,223.

Does Actuate Therapeutics, Inc. Common stock have any regulatory orders, red flags (PosiRed) or yellow flags (PosiYellow)?

Yes. Actuate Therapeutics, Inc. Common stock has 1 active red flag (PosiRed) on record: Stock exchange listing-rule deficiency notice (8-K Item 3.01) (dated 17 Jul 2026). It has no yellow flags.

Where can I read the latest news about Actuate Therapeutics, Inc. Common stock?

Recent headlines about Actuate Therapeutics, Inc. Common stock from the last 30 days, with links to the original articles, are on its News page on PositoAI.

Does Actuate Therapeutics, Inc. Common stock have a PositoAI PosiShot or QR code?

Yes. A dated PosiShot of Actuate Therapeutics, Inc. Common stock's current position, a PosiQR code for its live profile and a ready-made dated mention are available on its For this company page on PositoAI.